Could ketogenic diet “starve” cancer? Emerging evidence

References

• A D B. 1931. The ketogenic diet in epilepsy. Canadian Medical Association Journal 24 (1):106–7.
   PubMedGoogle Scholar
• Abdelwahab, M. G., K. E. Fenton, M. C. Preul, J. M. Rho, A. Lynch, P. Stafford, and A. C. Scheck. 2012. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One 7 (5):e36197. doi: 10.1371/journal.pone.0036197.
   PubMed Web of Science ®Google Scholar
• Aleksandrova, K., D. Mozaffarian, and T. Pischon. 2018. Addressing the perfect storm: Biomarkers in obesity and pathophysiology of cardiometabolic risk. Clinical Chemistry 64 (1):142–53. doi: 10.1373/clinchem.2017.275172.
   PubMed Web of Science ®Google Scholar
• Allen, B. G., S. K. Bhatia, C. M. Anderson, J. M. Eichenberger-Gilmore, Z. A. Sibenaller, K. A. Mapuskar, J. D. Schoenfeld, J. M. Buatti, D. R. Spitz, and M. A. Fath. 2014. Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biology 2:963–70. doi: 10.1016/j.redox.2014.08.002.
   PubMed Web of Science ®Google Scholar
• Allen, B. G., S. K. Bhatia, J. M. Buatti, K. E. Brandt, K. E. Lindholm, A. M. Button, L. I. Szweda, B. J. Smith, D. R. Spitz, and M. A. Fath. 2013. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clinical Cancer Research 19 (14):3905–13. doi: 10.1158/1078-0432.CCR-12-0287.
   PubMed Web of Science ®Google Scholar
• Altieri, B., L. Barrea, R. Modica, G. Muscogiuri, S. Savastano, A. Colao, and A. Faggiano. 2018. Nutrition and neuroendocrine tumors: An update of the literature. Reviews in Endocrine and Metabolic Disorders 19 (2):159–67. doi: 10.1007/s11154-018-9466-z.
   PubMed Web of Science ®Google Scholar
• Amano, K., I. Maeda, T. Morita, M. Baba, T. Miura, T. Hama, I. Mori, N. Nakajima, T. Nishi, H. Sakurai, et al. 2017. C-reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care. Journal of Cachexia, Sarcopenia and Muscle 8 (3):457–65. doi: 10.1002/jcsm.12184.
   PubMed Web of Science ®Google Scholar
• Aminzadeh-Gohari, S., R. G. Feichtinger, S. Vidali, F. Locker, T. Rutherford, M. O’Donnel, A. Stöger-Kleiber, J. A. Mayr, W. Sperl, and B. Kofler. 2017. A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model. Oncotarget 8 (39):64728–44. doi: 10.18632/oncotarget.20041.
   PubMedGoogle Scholar
• Arcidiacono, B., S. Iiritano, A. Nocera, K. Possidente, M. T. Nevolo, V. Ventura, D. Foti, E. Chiefari, and A. Brunetti. 2012. Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms. Experimental Diabetes Research 2012:789174. doi: 10.1155/2012/789174.
   PubMed Web of Science ®Google Scholar
• Arends, J., P. Bachmann, V. Baracos, N. Barthelemy, H. Bertz, F. Bozzetti, K. Fearon, E. Hütterer, E. Isenring, S. Kaasa, et al. 2017. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition 36 (1):11–48. doi: 10.1016/j.clnu.2016.07.015.
   PubMed Web of Science ®Google Scholar
• Artzi, M., G. Liberman, N. Vaisman, F. Bokstein, F. Vitinshtein, O. Aizenstein, and D. Ben Bashat. 2017. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study. Journal of Neuro-Oncology 132 (2):267–75. doi: 10.1007/s11060-016-2364-x.
   PubMed Web of Science ®Google Scholar
• Augustin, K., A. Khabbush, S. Williams, S. Eaton, M. Orford, J. H. Cross, S. J. R. Heales, M. C. Walker, and R. S. B. Williams. 2018. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. The Lancet. Neurology 17 (1):84–93. doi: 10.1016/S1474-4422(17)30408-8.
   PubMed Web of Science ®Google Scholar
• Avgerinos, K. I., N. Spyrou, C. S. Mantzoros, and M. Dalamaga. 2019. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism: Clinical and Experimental 92:121–35. doi: 10.1016/j.metabol.2018.11.001.
   PubMed Web of Science ®Google Scholar
• Bandera, E. V., S. H. Fay, E. Giovannucci, M. F. Leitzmann, R. Marklew, A. McTiernan, A. Mullee, I. Romieu, I. Thune, R. Uauy, et al. 2016. The use and interpretation of anthropometric measures in cancer epidemiology: A perspective from the world cancer research fund international continuous update project. International Journal of Cancer 139 (11):2391–7. doi: 10.1002/ijc.30248.
   PubMed Web of Science ®Google Scholar
• Baracos, V. E. 2015. Skeletal muscle anabolism in patients with advanced cancer. The Lancet. Oncology 16 (1):13–4. doi: 10.1016/S1470-2045(14)71185-4.
   PubMed Web of Science ®Google Scholar
• Baracos, V. E., L. Martin, M. Korc, D. C. Guttridge, and K. C. H. Fearon. 2018. Cancer-associated cachexia. Nature Reviews Disease Primers 4 (1):17105. doi: 10.1038/nrdp.2017.105.
   PubMedGoogle Scholar
• Barrea, L., B. Altieri, G. Muscogiuri, D. Laudisio, G. Annunziata, A. Colao, A. Faggiano, and S. Savastano. 2018. Impact of nutritional status on gastroenteropancreatic neuroendocrine tumors (GEP-NET) aggressiveness. Nutrients 10 (12):1854. doi: 10.3390/nu10121854.
   PubMed Web of Science ®Google Scholar
• Barrea, L., F. Fonderico, C. Di Somma, G. Pugliese, G. De Alteriis, M. Mascolo, A. Colao, and S. Savastano. 2020. Thyroid papillary carcinoma arising in ectopic thyroid tissue within sternocleidomastoid muscle: Case report and review of current literature. Minerva Endocrinologica. doi: 10.23736/S0391-1977.20.03167-3. Epub ahead of print. PMID: 32744438.
   Web of Science ®Google Scholar
• Barrea, L., M. Gallo, R. M. Ruggeri, P. Giacinto, F. Di Sesti, N. Prinzi, V. Adinolfi, V. Barucca, V. Renzelli, G. Muscogiuri, et al. 2020. Nutritional status and follicular-derived thyroid cancer: An update. Critical Reviews in Food Science and Nutrition 30:1–35. doi: 10.1080/10408398.2020.1714542. Epub ahead of print. PMID: 31997660.
   Google Scholar
• Barrea, L., M. Megna, S. Cacciapuoti, E. Frias-Toral, G. Fabbrocini, S. Savastano, A. Colao, and G. Muscogiuri. 2020. Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: An update for dermatologists and nutritionists. Critical Reviews in Food Science and Nutrition 24:1–17. doi: 10.1080/10408398.2020.1818053. Online ahead of print. PMID: 32969257
   Google Scholar
• Beck, S. A., and M. J. Tisdale. 1989. Effect of insulin on weight loss and tumour growth in a cachexia model. British Journal of Cancer 59 (5):677–81. doi: 10.1038/bjc.1989.140.
   PubMed Web of Science ®Google Scholar
• Belfiore, A., and R. Malaguarnera. 2011. Insulin receptor and cancer. Endocrine-Related Cancer 18 (4):R125-47. doi: 10.1530/ERC-11-0074.
   PubMed Web of Science ®Google Scholar
• Bhattacharya, B., M. F. Mohd Omar, and R. Soong. 2016. The Warburg effect and drug resistance. British Journal of Pharmacology 173 (6):970–9. doi: 10.1111/bph.13422.
   PubMed Web of Science ®Google Scholar
• Bingham, S. A., N. E. Day, R. Luben, P. Ferrari, N. Slimani, T. Norat, F. Clavel-Chapelon, E. Kesse, A. Nieters, H. Boeing, et al. 2003. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): An observational study. Lancet 361 (9368):1496–501. doi: 10.1016/S0140-6736(03)13174-1.
   PubMed Web of Science ®Google Scholar
• Birks, S., A. Peeters, K. Backholer, P. O’Brien, and W. Brown. 2012. A systematic review of the impact of weight loss on cancer incidence and mortality. Obesity Reviews 13 (10):868–91. doi: 10.1111/j.1467-789X.2012.01010.x.
   PubMed Web of Science ®Google Scholar
• Boden, G., K. Sargrad, C. Homko, M. Mozzoli, and T. P. Stein. 2005. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Annals of Internal Medicine 142 (6):403. doi: 10.7326/0003-4819-142-6-200503150-00006.
   PubMed Web of Science ®Google Scholar
• Bonuccelli, G., A. Tsirigos, D. Whitaker-Menezes, S. Pavlides, R. G. Pestell, B. Chiavarina, P. G. Frank, N. Flomenberg, A. Howell, U. E. Martinez-Outschoorn, et al. 2010. Ketones and lactate “fuel” tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9 (17):3506–14. doi: 10.4161/cc.9.17.12731.
   PubMed Web of Science ®Google Scholar
• Bose, S., and A. Le. 2018. Glucose metabolism in cancer. In Advances in experimental medicine and biology, ed. A. Le, 3–12. Cham: Springer. doi: 10.1007/978-3-319-77736-8_1.
   Google Scholar
• Boyd, D. B. 2003. Insulin and cancer. Integrative Cancer Therapies 2 (4):315–29. doi: 10.1177/1534735403259152.
   PubMedGoogle Scholar
• Brault, C., and A. Schulze. 2016. The role of glucose and lipid metabolism in growth and survival of cancer cells. Recent Results in Cancer Research 207:1–22. doi: 10.1007/978-3-319-42118-6_1.
   PubMedGoogle Scholar
• Bueno, N. B., I. S. V. De Melo, S. L. De Oliveira, and T. Da Rocha Ataide. 2013. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: A meta-analysis of Randomised controlled trials. British Journal of Nutrition 110 (7):1178–87. doi: 10.1017/S0007114513000548.
   PubMed Web of Science ®Google Scholar
• Caccialanza, R., E. Cereda, F. De Lorenzo, G. Farina, and P. Pedrazzoli. 2018. To fast, or not to fast before chemotherapy, that is the question. BMC Cancer 18 (1) doi: 10.1186/s12885-018-4245-5.
   PubMedGoogle Scholar
• Cahill, G. F. 1976. Starvation in man. Clinics in Endocrinology and Metabolism 5 (2):397–415. doi: 10.1016/S0300-595X(76)80028-X.
   PubMedGoogle Scholar
• Calle, E. E., C. Rodriguez, K. Walker-Thurmond, and M. J. Thun. 2003. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 348 (17):1625–38. doi: 10.1056/NEJMoa021423.
   PubMed Web of Science ®Google Scholar
• Caprio, M., M. Infante, E. Moriconi, A. Armani, A. Fabbri, G. Mantovani, S. Mariani, C. Lubrano, E. Poggiogalle, S. Migliaccio, et al. 2019. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: Systematic review and consensus statement from the Italian Society of Endocrinology (SIE). Journal of Endocrinological Investigation 42 (11):1365–86. doi: 10.1007/s40618-019-01061-2.
   PubMed Web of Science ®Google Scholar
• Caso, J., E. M. Masko, J. A. T. Ii, S. H. Poulton, M. Dewhirst, S. V. Pizzo, and S. J. Freedland. 2013. The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model. The Prostate 73 (5):449–54. doi: 10.1002/pros.22586.
   PubMed Web of Science ®Google Scholar
• Castellana, M., E. Conte, A. Cignarelli, S. Perrini, A. Giustina, L. Giovanella, F. Giorgino, and P. Trimboli. 2020. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders 21 (1):5–16. doi: 10.1007/s11154-019-09514-y.
   PubMed Web of Science ®Google Scholar
• Champ, C. E., J. D. Palmer, J. S. Volek, M. Werner-Wasik, D. W. Andrews, J. J. Evans, J. Glass, L. Kim, and W. Shi. 2014. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. Journal of Neuro-Oncology 117 (1):125–31. doi: 10.1007/s11060-014-1362-0.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay, E., and B. Roy. 2017. Altered mitochondrial signalling and metabolism in cancer. Frontiers in Oncology 7:43. doi: 10.3389/fonc.2017.00043.
   PubMed Web of Science ®Google Scholar
• Chiche, J., M. C. Brahimi-Horn, and J. Pouysségur. 2010. Tumour hypoxia induces a metabolic shift causing acidosis: A common feature in cancer. Journal of Cellular and Molecular Medicine 14 (4):771–94. doi: 10.1111/j.1582-4934.2009.00994.x.
   PubMed Web of Science ®Google Scholar
• Christofk, H. R., M. G. Vander Heiden, M. H. Harris, A. Ramanathan, R. E. Gerszten, R. Wei, M. D. Fleming, S. L. Schreiber, and L. C. Cantley. 2008. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452 (7184):230–3. doi: 10.1038/nature06734.
   PubMed Web of Science ®Google Scholar
• Cohen, C. W., K. R. Fontaine, R. C. Arend, R. D. Alvarez, C. A. Leath, W. K. Huh, K. S. Bevis, K. H. Kim, J. M. Straughn, and B. A. Gower. 2018. A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer. Journal of Nutrition 148 (8):1253–60. doi: 10.1093/jn/nxy119.
   PubMed Web of Science ®Google Scholar
• Cooder, H. R. 1933. Epilepsy in children: With particular reference to the ketogenic diet. California and Western Medicine 39 (3):169–73.
   PubMedGoogle Scholar
• Cunha, G. M., G. Guzman, L. L. Correa De Mello, B. Trein, L. Spina, I. Bussade, J. Marques Prata, I. Sajoux, and W. Countinho. 2020. Efficacy of a 2-month very low-calorie ketogenic diet (VLCKD) compared to a standard low-calorie diet in reducing visceral and liver fat accumulation in patients with obesity. Frontiers in Endocrinology 11:607. doi: 10.3389/fendo.2020.00607.
   PubMed Web of Science ®Google Scholar
• D’Agostino, D. P., J. E. Olson, and J. B. Dean. 2009. Acute hyperoxia increases lipid peroxidation and induces plasma membrane blebbing in human U87 glioblastoma cells. Neuroscience 159 (3):1011–22. doi: 10.1016/j.neuroscience.2009.01.062.
   PubMed Web of Science ®Google Scholar
• De Beer, J. C., and L. Liebenberg. 2014. Does cancer risk increase with HbA 1c, independent of diabetes? British Journal of Cancer 110 (9):2361–8. doi: 10.1038/bjc.2014.150.
   PubMed Web of Science ®Google Scholar
• De Berardinis, R. J., and N. S. Chandel. 2016. Fundamentals of cancer metabolism. Science Advances 2 (5):e1600200. doi: 10.1126/sciadv.1600200.
   PubMed Web of Science ®Google Scholar
• DeBerardinis, R. J., J. J. Lum, G. Hatzivassiliou, and C. B. Thompson. 2008. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism 7 (1):11–20. doi: 10.1016/j.cmet.2007.10.002.
   PubMed Web of Science ®Google Scholar
• Demark-Wahnefried, W., K. L. Campbell, and S. C. Hayes. 2012. Weight management and its role in breast cancer rehabilitation. Cancer 118 (S8):2277–87. doi: 10.1002/cncr.27466.
   PubMedGoogle Scholar
• Deng, T., C. J. Lyon, S. Bergin, M. A. Caligiuri, and W. A. Hsueh. 2016. Obesity, Inflammation, and Cancer. Annual Review of Pathology: Mechanisms of Disease 11:421–49. doi: 10.1146/annurev-pathol-012615-044359.
   PubMed Web of Science ®Google Scholar
• Diakos, C. I., K. A. Charles, D. C. McMillan, and S. J. Clarke. 2014. Cancer-related inflammation and treatment effectiveness. The Lancet. Oncology 15 (11):e493–503. doi: 10.1016/S1470-2045(14)70263-3.
   PubMed Web of Science ®Google Scholar
• Eltzschig, H. K., and P. Carmeliet. 2011. Hypoxia and inflammation. New England Journal of Medicine 364 (7):656–65. doi: 10.1056/NEJMra0910283.
   PubMed Web of Science ®Google Scholar
• Evans, M., K. E. Cogan, and B. Egan. 2017. Metabolism of ketone bodies during exercise and training: Physiological basis for exogenous supplementation. Journal of Physiology doi: 10.1113/JP273185.
   PubMed Web of Science ®Google Scholar
• Fantin, V. R., J. St-Pierre, and P. Leder. 2006. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9 (6):425–34. doi: 10.1016/j.ccr.2006.04.023.
   PubMed Web of Science ®Google Scholar
• Fearon, K. C. H., W. Borland, T. Preston, M. J. Tisdale, A. Shenkin, and K. C. Calman. 1988. Cancer cachexia: Influence of systemic ketosis on substrate levels and nitrogen metabolism. The American Journal of Clinical Nutrition 47 (1):42–8. doi: 10.1093/ajcn/47.1.42.
   PubMed Web of Science ®Google Scholar
• Fearon, K., F. Strasser, S. D. Anker, I. Bosaeus, E. Bruera, R. L. Fainsinger, A. Jatoi, C. Loprinzi, N. MacDonald, G. Mantovani, et al. 2011. Definition and classification of cancer cachexia: An international consensus. The Lancet Oncology 12 (5):489–95. doi: 10.1016/S1470-2045(10)70218-7.
   PubMed Web of Science ®Google Scholar
• Filomeno, M., C. Bosetti, E. Bidoli, F. Levi, D. Serraino, M. Montella, C. La Vecchia, and A. Tavani. 2015. Mediterranean diet and risk of endometrial cancer: A pooled analysis of three Italian case-control studies. British Journal of Cancer 112 (11):1816–21. doi: 10.1038/bjc.2015.153.
   PubMed Web of Science ®Google Scholar
• Fine, E. J., A. Miller, E. V. Quadros, J. M. Sequeira, and R. D. Feinman. 2009. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell International 9 (1):14. doi: 10.1186/1475-2867-9-14.
   PubMedGoogle Scholar
• Fine, E. J., C. J. Segal-Isaacson, R. D. Feinman, S. Herszkopf, M. C. Romano, N. Tomuta, A. F. Bontempo, A. Negassa, and J. A. Sparano. 2012. Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients. Nutrition 28 (10):1028–35. doi: 10.1016/j.nut.2012.05.001.
   PubMed Web of Science ®Google Scholar
• Fontana, L., R. M. Adelaiye, A. L. Rastelli, K. M. Miles, E. Ciamporcero, V. D. Longo, H. Nguyen, R. Vessella, and R. Pili. 2013. Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer. Oncotarget 4 (12):2451–61. doi: 10.18632/oncotarget.1586.
   PubMedGoogle Scholar
• Forsythe, C. E., S. D. Phinney, M. L. Fernandez, E. E. Quann, R. J. Wood, D. M. Bibus, W. J. Kraemer, R. D. Feinman, and J. S. Volek. 2008. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 43 (1):65–77. doi: 10.1007/s11745-007-3132-7.
   PubMed Web of Science ®Google Scholar
• Fruehauf, J. P., and F. L. Meyskens. 2007. Reactive oxygen species: A breath of life or death? Clinical Cancer Research 13 (3):789–94. doi: 10.1158/1078-0432.CCR-06-2082.
   PubMed Web of Science ®Google Scholar
• Fuentes-Raspall, R., M. Puig-Vives, S. Guerra-Prio, F. Perez-Bueno, and R. Marcos-Gragera. 2014. Population-based survival analyses of central nervous system tumors from 1994 to 2008. An up-dated study in the temozolomide-era. Cancer Epidemiology 38 (3):244–7. doi: 10.1016/j.canep.2014.03.014.
   PubMed Web of Science ®Google Scholar
• Gallo, M., V. Adinolfi, V. Barucca, N. Prinzi, V. Renzelli, L. Barrea, P. Di Giacinto, R. M. Ruggeri, F. Sesti, E. Arvat, et al. 2020. Expected and paradoxical effects of obesity on cancer treatment response. Reviews in Endocrine and Metabolic Disorders. doi: 10.1007/s11154-020-09597-y. Online ahead of print. PMID: 33025385
   Web of Science ®Google Scholar
• Gallo, M., G. Muscogiuri, G. Pizza, R. M. Ruggeri, L. Barrea, A. Faggiano, and A. Colao. 2019. The management of neuroendocrine tumours: A nutritional viewpoint. Critical Reviews in Food Science and Nutrition 59 (7):1046–57. doi: 10.1080/10408398.2017.1390729.
   PubMed Web of Science ®Google Scholar
• Gasior, M., M. A. Rogawski, and A. L. Hartman. 2006. Neuroprotective and disease-modifying effects of the ketogenic diet. Behavioural Pharmacology 17 (5–6):431–9. doi: 10.1097/00008877-200609000-00009.
   PubMed Web of Science ®Google Scholar
• Gibson, A. A., R. V. Seimon, C. M. Y. Lee, J. Ayre, J. Franklin, T. P. Markovic, I. D. Caterson, and A. Sainsbury. 2015. Do ketogenic diets really suppress appetite? A systematic review and meta-analysis. Obesity Reviews 16 (1):64–76. doi: 10.1111/obr.12230.
   PubMed Web of Science ®Google Scholar
• Gilardini, L., R. Cancello, K. Caffetto, R. Cottafava, I. Gironi, and C. Invitti. 2020. Nutrition knowledge is associated with greater weight loss in obese patients following a multidisciplinary rehabilitaiton program. Minerva Endocrinologica. doi: 10.23736/S0391-1977.20.03212-5. Epub ahead of print. PMID: 32720499.
   Google Scholar
• Glew, R. H. 2010. You can get there from here: Acetone, Anionic ketones and even-carbon fatty acids can provide Substrates for gluconeogenesis. Nigerian Journal of Physiological Sciences 25 (1):2–4.
   PubMedGoogle Scholar
• Greten, F. R., and S. I. Grivennikov. 2019. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity 51 (1):27–41. doi: 10.1016/j.immuni.2019.06.025.
   PubMed Web of Science ®Google Scholar
• Gupta, G. P., and J. Massagué. 2006. Cancer metastasis: Building a framework. Cell 127 (4):679–95. doi: 10.1016/j.cell.2006.11.001.
   PubMed Web of Science ®Google Scholar
• Gupta, L., D. Khandelwal, S. Kalra, P. Gupta, D. Dutta, and S. Aggarwal. 2017. Ketogenic diet in endocrine disorders: Current perspectives. Journal of Postgraduate Medicine 63 (4):242. doi: 10.4103/jpgm.JPGM_16_17.
   PubMed Web of Science ®Google Scholar
• Guzmán, M., and C. Blázquez. 2004. Ketone body synthesis in the brain: Possible neuroprotective effects. Prostaglandins Leukotrienes and Essential Fatty Acids 70 (3):287–92. doi: 10.1016/j.plefa.2003.05.001.
   PubMed Web of Science ®Google Scholar
• Hae-Yun Chung, R., and Y. Kyoung Park. 2017. Rationale, feasibility and acceptability of ketogenic diet for cancer treatment. Journal of Cancer Prevention 22 (3):127–34. doi: 10.15430/JCP.2017.22.3.127.
   PubMed Web of Science ®Google Scholar
• Hamanaka, R. B., and N. S. Chandel. 2010. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends in Biochemical Sciences 35 (9):505–13. doi: 10.1016/j.tibs.2010.04.002.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of cancer: The next generation. Cell 144 (5):646–74. doi: 10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Hao, G. W., Y. S. Chen, D. M. He, H. Y. Wang, G. H. Wu, and B. Zhang. 2015. Growth of human colon cancer cells in nude mice is delayed by ketogenic diet with or without omega-3 fatty acids and medium-chain triglycerides. Asian Pacific Journal of Cancer Prevention: APJCP 16 (5):2061–8. doi: 10.7314/APJCP.2015.16.5.2061.
   PubMedGoogle Scholar
• Harber, M. P., S. Schenk, A. L. Barkan, and J. F. Horowitz. 2005. Effects of dietary carbohydrate restriction with high protein intake on protein metabolism and the somatotropic axis. Journal of Clinical Endocrinology and Metabolism 90 (9):5175–81. doi: 10.1210/jc.2005-0559.
   PubMed Web of Science ®Google Scholar
• Harris, A. L. 2002. Hypoxia: A key regulatory factor in tumour growth. Nature Reviews. Cancer 2 (1):38–47. doi: 10.1038/nrc704.
   PubMed Web of Science ®Google Scholar
• Heiden, M. G. V., L. C. Cantley, and C. B. Thompson. 2009. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324 (5930):1029–33. doi: 10.1126/science.1160809.
   PubMed Web of Science ®Google Scholar
• Hileman, E. O., J. Liu, M. Albitar, M. J. Keating, and P. Huang. 2004. Intrinsic oxidative stress in cancer cells: A biochemical basis for therapeutic selectivity. Cancer Chemotherapy and Pharmacology 53 (3):209–19. doi: 10.1007/s00280-003-0726-5.
   PubMed Web of Science ®Google Scholar
• Ho, V. W., K. Leung, A. Hsu, B. Luk, J. Lai, S. Y. Shen, A. I. Minchinton, D. Waterhouse, M. B. Bally, W. Lin, et al. 2011. A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Research 71 (13):4484–93. doi: 10.1158/0008-5472.CAN-10-3973.
   PubMed Web of Science ®Google Scholar
• Höhn, S., B. Dozières-Puyravel, and S. Auvin. 2019. History of dietary treatment: Guelpa & Marie first report of intermittent fasting for epilepsy in 1911. Epilepsy and Behavior 94:277–80. doi: 10.1016/j.yebeh.2019.03.018.
   PubMed Web of Science ®Google Scholar
• Hopkins, B. D., C. Pauli, D. Xing, D. G. Wang, X. Li, D. Wu, S. C. Amadiume, M. D. Goncalves, C. Hodakoski, M. R. Lundquist, et al. 2018. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560 (7719):499–503. doi: 10.1038/s41586-018-0343-4.
   PubMed Web of Science ®Google Scholar
• Hsu, C. C., L. M. Tseng, and H. C. Lee. 2016. Role of mitochondrial dysfunction in cancer progression. Experimental Biology and Medicine 241 (12):1281–95. doi: 10.1177/1535370216641787.
   PubMed Web of Science ®Google Scholar
• Hsu, P. P., and D. M. Sabatini. 2008. Cancer cell metabolism: Warburg and beyond. Cell 134 (5):703–7. doi: 10.1016/j.cell.2008.08.021.
   PubMed Web of Science ®Google Scholar
• Hursting, S. D., S. M. Dunlap, N. A. Ford, M. J. Hursting, and L. M. Lashinger. 2013. Calorie restriction and cancer prevention: A mechanistic perspective. Cancer & Metabolism 7 (1):10. doi: 10.1186/2049-3002-1-10.
   Google Scholar
• Iguchi, T., N. Takasugi, N. Nishimura, and S. Kusunoki. 1989. Correlation between mammary tumor and blood glucose, serum insulin, and free fatty acids in mice. Cancer Research 49 (4):821–5.
   PubMed Web of Science ®Google Scholar
• Iyengar, N. M., A. Gucalp, A. J. Dannenberg, and C. A. Hudis. 2016. Obesity and cancer mechanisms: Tumor microenvironment and inflammation. Journal of Clinical Oncology 34 (35):4270–6. doi: 10.1200/JCO.2016.67.4283.
   PubMed Web of Science ®Google Scholar
• Iyikesici, M. S. 2019. Feasibility study of metabolically supported chemotherapy with weekly carboplatin/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer. International Journal of Hyperthermia 36 (1):445–54. doi: 10.1080/02656736.2019.1589584.
   PubMed Web of Science ®Google Scholar
• Jain, S. K., K. Kannan, and G. Lim. 1998. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radical Biology & Medicine 25 (9):1083–8. doi: 10.1016/S0891-5849(98)00140-3.
   PubMed Web of Science ®Google Scholar
• Kasumi, E., and N. Sato. 2019. A ketogenic diet improves the prognosis in a mouse model of peritoneal dissemination without tumor regression. Journal of Clinical Biochemistry and Nutrition 64 (3):201–8. doi: 10.3164/jcbn.18-103.
   PubMed Web of Science ®Google Scholar
• Khodabakhshi, A., M. E. Akbari, H. R. Mirzaei, H. Mehrad-Majd, M. Kalamian, and S. H. Davoodi. 2020. Feasibility, safety, and beneficial effects of MCT-based ketogenic diet for breast cancer treatment: A randomized controlled trial study. Nutrition and Cancer 72 (4):627–34. doi: 10.1080/01635581.2019.1650942.
   PubMed Web of Science ®Google Scholar
• Kim, J. W., I. Tchernyshyov, G. L. Semenza, and C. V. Dang. 2006. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism 3 (3):177–85. doi: 10.1016/j.cmet.2006.02.002.
   PubMed Web of Science ®Google Scholar
• Klement, R. J. 2013. Calorie or carbohydrate restriction? The ketogenic diet as another option for supportive cancer treatment. The Oncologist 18 (9):1056. doi: 10.1634/theoncologist.2013-0032.
   PubMed Web of Science ®Google Scholar
• Klement, R. J. 2014. Mimicking caloric restriction: What about macronutrient manipulation? A response to Meynet and Ricci. Trends in Molecular Medicine 20 (9):471–2. doi: 10.1016/j.molmed.2014.07.001.
   PubMed Web of Science ®Google Scholar
• Klement, R. J. 2018. Fasting, fats, and physics: Combining ketogenic and radiation therapy against cancer. Complementary Medicine Research 25 (2):102–13. doi: 10.1159/000484045.
   PubMed Web of Science ®Google Scholar
• Klement, R. J. 2019a. The emerging role of ketogenic diets in cancer treatment. Current Opinion in Clinical Nutrition and Metabolic Care 22 (2):129–34. doi: 10.1097/MCO.0000000000000540.
   PubMed Web of Science ®Google Scholar
• Klement, R. J. 2019b. The influence of ketogenic therapy on the 5 R’s of radiobiology. International Journal of Radiation Biology 95 (4):394–407.
   PubMed Web of Science ®Google Scholar
• Klement, R. J., and M. K. Fink. 2016. Dietary and pharmacological modification of the insulin/IGF-1 system: Exploiting the full repertoire against cancer. Oncogenesis 5 (2):e193. doi: 10.1038/oncsis.2016.2.
   PubMedGoogle Scholar
• Klement, R. J., N. Brehm, and R. A. Sweeney. 2020. Ketogenic diets in medical oncology: A systematic review with focus on clinical outcomes. Medical Oncology 37 (2):14. doi: 10.1007/s12032-020-1337-2.
   PubMed Web of Science ®Google Scholar
• Klement, R. J., and R. A. Sweeney. 2016. Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients. BMC Research Notes 9 (1):143. doi: 10.1186/s13104-016-1959-9.
   PubMedGoogle Scholar
• Kong, Q., J. A. Beel, and K. O. Lillehei. 2000. A threshold concept for cancer therapy. Medical Hypotheses 55 (1):29–35. doi: 10.1054/mehy.1999.0982.
   PubMed Web of Science ®Google Scholar
• Koroljow, S. 1962. Two cases of malignant tumors with metastases apparently treated successfully with hypoglycemic coma. The Psychiatric Quarterly 36 (1–4):261–70. doi: 10.1007/BF01586115.
   PubMedGoogle Scholar
• Kossoff, E. H., and A. L. Hartman. 2012. Ketogenic diets: New advances for metabolismbased therapies. Current Opinion in Neurology 25 (2):173–8. doi: 10.1097/WCO.0b013e3283515e4a.
   PubMed Web of Science ®Google Scholar
• Kossoff, E. H., B. A. Zupec-Kania, S. Auvin, K. R. Ballaban-Gil, A. G. Christina Bergqvist, R. Blackford, J. R. Buchhalter, R. H. Caraballo, J. H. Cross, M. G. Dahlin, et al. 2018. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 3 (2):175–92. doi: 10.1002/epi4.12225.
   PubMedGoogle Scholar
• Kroemer, G., and J. Pouyssegur. 2008. Tumor cell metabolism: Cancer’s Achilles’ heel. Cancer Cell 13 (6):472–82. doi: 10.1016/j.ccr.2008.05.005.
   PubMed Web of Science ®Google Scholar
• Kwiterovich, P. O., E. P. G. Vining, P. Pyzik, R. Skolasky, and J. M. Freeman. 2003. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. Journal of the American Medical Association 290 (7):912–20. doi: 10.1001/jama.290.7.912.
   PubMed Web of Science ®Google Scholar
• Laffel, L. 1999. Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes/Metabolism Research and Reviews 15 (6):412–26. doi: 10.1002/(sici)1520-7560(199911/12)15:6 < 412::aid-dmrr72 > 3.0.co;2-8.
   PubMed Web of Science ®Google Scholar
• Lamming, D. W., N. E. Cummings, A. L. Rastelli, F. Gao, E. Cava, B. Bertozzi, F. Spelta, R. Pili, and L. Fontana. 2015. Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model. Oncotarget 6 (31):31233–40. doi: 10.18632/oncotarget.5180.
   PubMedGoogle Scholar
• Lanza-Jacoby, S., G. Yan, G. Radice, C. LePhong, J. Baliff, and R. Hess. 2013. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer. Experimental Biology and Medicine 238 (7):787–97. doi: 10.1177/1535370213493727.
   Web of Science ®Google Scholar
• Lauby-Secretan, B., C. Scoccianti, D. Loomis, Y. Grosse, F. Bianchini, and K. Straif. 2016. Body fatness and cancer: Viewpoint of the IARC working group. New England Journal of Medicine 375 (8):794–8. doi: 10.1056/NEJMsr1606602.
   PubMed Web of Science ®Google Scholar
• Laudisio, D., L. Barrea, G. Muscogiuri, G. Annunziata, A. Colao, and S. Savastano. 2020. Breast cancer prevention in premenopausal women: Role of the Mediterranean diet and its components. Nutrition Research Reviews 33 (1):19–32. doi: 10.1017/S0954422419000167.
   PubMed Web of Science ®Google Scholar
• Laudisio, D., G. Muscogiuri, L. Barrea, S. Savastano, and A. Colao. 2018. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives. European Journal of Obstetrics Gynecology and Reproductive Biology 230:217–21. doi: 10.1016/j.ejogrb.2018.03.050.
   PubMed Web of Science ®Google Scholar
• Lee, C., L. Raffaghello, S. Brandhorst, F. M. Safdie, G. Bianchi, A. Martin-Montalvo, V. Pistoia, M. Wei, S. Hwang, A. Merlino, et al. 2012. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science Translational Medicine 4 (124):124ra27. doi: 10.1126/scitranslmed.3003293.
   PubMed Web of Science ®Google Scholar
• Leidy, H. J., P. M. Clifton, A. Astrup, T. P. Wycherley, M. S. Westerterp-Plantenga, N. D. Luscombe-Marsh, S. C. Woods, and R. D. Mattes. 2015. The role of protein in weight loss and maintenance. American Journal of Clinical Nutrition 101 (6):1320S–9S. doi: 10.3945/ajcn.114.084038.
   PubMed Web of Science ®Google Scholar
• Lennon, H., M. Sperrin, E. Badrick, and A. G. Renehan. 2016. The obesity paradox in cancer: A review. Current Oncology Reports 18 (9):56. doi: 10.1007/s11912-016-0539-4.
   PubMed Web of Science ®Google Scholar
• Leone, T. C., C. J. Weinheimer, and D. P. Kelly. 1999. A critical role for the peroxisome proliferator-activated receptor Tα (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders. Proceedings of the National Academy of Sciences of the United States of America 96 (13):7473–8. doi: 10.1073/pnas.96.13.7473.
   PubMed Web of Science ®Google Scholar
• Li, L., and Y. Liu. 2015. Aging-related gene signature regulated by Nlrp3 predicts glioma progression. American Journal of Cancer Research 5 (1):442–9.
   PubMed Web of Science ®Google Scholar
• Liang, J., and J. M. Slingerland. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2 (4):336–42. oi: doi: 10.4161/cc.2.4.433.
   Web of Science ®Google Scholar
• Lin, B. Q., Z. Y. Zeng, S. S. Yang, and C. W. Zhuang. 2013. Dietary restriction suppresses tumor growth, reduces angiogenesis, and improves tumor microenvironment in human non-small-cell lung cancer xenografts. Lung Cancer 79 (2):111–7. doi: 10.1016/j.lungcan.2012.11.001.
   PubMed Web of Science ®Google Scholar
• Lindmark, L., E. Eden, and M. Ternell. 1986. Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight. Annals of Surgery 204 (6):628–36. doi: 10.1097/00000658-198612000-00003.
   PubMed Web of Science ®Google Scholar
• Liśkiewicz, A. D., D. Kasprowska, A. Wojakowska, K. Polański, J. Lewin-Kowalik, K. Kotulska, and H. Jędrzejowska-Szypułka. 2016. Long-term high fat ketogenic diet promotes renal tumor growth in a rat model of tuberous sclerosis. Scientific Reports 6:21807. doi: 10.1038/srep21807.
   PubMed Web of Science ®Google Scholar
• Lu, M., S. Amano, K. Miyamoto, R. Garland, K. Keough, W. Qin, and A. P. Adamis. 1999. Insulin-induced vascular endothelial growth factor expression in retina. Investigative Ophthalmology and Visual Science 40 (13):3281–6.
   PubMed Web of Science ®Google Scholar
• Lv, M., X. Zhu, H. Wang, F. Wang, and W. Guan. 2014. Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: A systematic review and meta-analysis. PLoS One 9 (12):e115147. doi: 10.1371/journal.pone.0115147.
   PubMed Web of Science ®Google Scholar
• Maalouf, M., J. M. Rho, and M. P. Mattson. 2009. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Research Reviews 59 (2):293–315. doi: 10.1016/j.brainresrev.2008.09.002.
   PubMedGoogle Scholar
• MacDonald, A. J., N. Johns, N. Stephens, C. Greig, J. A. Ross, A. C. Small, H. Husi, K. C. H. Fearon, and T. Preston. 2015. Habitual myofibrillar protein synthesis is normalin patients with upper GI cancer cachexia. Clinical Cancer Research 21 (7):1734–40. doi: 10.1158/1078-0432.CCR-14-2004.
   PubMed Web of Science ®Google Scholar
• Magee, B. A., N. Potezny, A. M. Rofe, and R. A. J. Conyers. 1979. The inhibition of malignant cell growth by ketone bodies. Australian Journal of Experimental Biology and Medical Science 57 (5):529–39. doi: 10.1038/icb.1979.54.
   PubMedGoogle Scholar
• MARIE, L. D. A. 1911. La lutte contrjz l’épilepsie par la rééducation alimentaire. Epilepsia A2 (3):265–73. doi: 10.1111/j.1528-1157.1911.tb03003.x.
   Google Scholar
• Martin-McGill, K. J., A. G. Marson, C. Tudur Smith, B. Young, S. J. Mills, M. G. Cherry, and M. D. Jenkinson. 2020. Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): A randomized, mixed methods, feasibility study. Journal of Neuro-oncology 147 (1):213–27. doi: 10.1007/s11060-020-03417-8.
   PubMed Web of Science ®Google Scholar
• Martin, L., L. Birdsell, N. MacDonald, T. Reiman, M. T. Clandinin, L. J. McCargar, R. Murphy, S. Ghosh, M. B. Sawyer, and V. E. Baracos. 2013. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. Journal of Clinical Oncology 31 (12):1539–47. doi: 10.1200/JCO.2012.45.2722.
   PubMed Web of Science ®Google Scholar
• Martin, L., P. Senesse, I. Gioulbasanis, S. Antoun, F. Bozzetti, C. Deans, F. Strasser, L. Thoresen, R. T. Jagoe, M. Chasen, et al. 2015. Diagnostic criteria for the classification of cancer-associated weight loss. Journal of Clinical Oncology 33 (1):90–9. doi: 10.1200/JCO.2014.56.1894.
   PubMed Web of Science ®Google Scholar
• Martuscello, R. T., V. Vedam-Mai, D. J. McCarthy, M. E. Schmoll, M. A. Jundi, C. D. Louviere, B. G. Griffith, C. L. Skinner, O. Suslov, L. P. Deleyrolle, et al. 2016. A supplemented high-fat low-carbohydrate diet for the treatment of glioblastoma. Clinical Cancer Research 22 (10):2482–95. doi: 10.1158/1078-0432.CCR-15-0916.
   PubMed Web of Science ®Google Scholar
• McBride, H. M., M. Neuspiel, and S. Wasiak. 2006. Mitochondria: More than just a powerhouse. Current Biology 16 (14):R551–60. doi: 10.1016/j.cub.2006.06.054.
   PubMed Web of Science ®Google Scholar
• McGarry, J. D., and D. W. Foster. 1980. Regulation of hepatic fatty acid oxidation and ketone body production. Annual Review of Biochemistry 49 (1):395–420. doi: 10.1146/annurev.bi.49.070180.002143.
   PubMedGoogle Scholar
• Memmott, R. M., and P. A. Dennis. 2009. Akt-dependent and-independent mechanisms of mTOR regulation in cancer. Cellular Signalling 21 (5):656–64. doi:10.1016/j.cellsig.2009.01.004. PMC: 19166931
   PubMed Web of Science ®Google Scholar
• Miuma, S., T. Ichikawa, K. Arima, S. Takeshita, T. Muraoka, T. Matsuzaki, M. Ootani, H. Shibata, M. Akiyama, E. Ozawa, et al. 2012. Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells. Journal of Cellular Biochemistry 113 (10):3113–21. doi: 10.1002/jcb.24188.
   PubMed Web of Science ®Google Scholar
• Mole, D. R., C. Blancher, R. R. Copley, P. J. Pollard, J. M. Gleadle, J. Ragoussis, and P. J. Ratcliffe. 2009. Genome-wide association of hypoxia-inducible factor (HIF)-1α and HIF-2α DNA binding with expression profiling of hypoxia-inducible transcripts. Journal of Biological Chemistry 284 (25):16767–75. doi: 10.1074/jbc.M901790200.
   PubMed Web of Science ®Google Scholar
• Moossavi, M., N. Parsamanesh, A. Bahrami, S. L. Atkin, and A. Sahebkar. 2018. Role of the NLRP3 inflammasome in cancer. Molecular Cancer 17 (1):158. doi: 10.1186/s12943-018-0900-3.
   PubMed Web of Science ®Google Scholar
• Moreno-Sánchez, R., S. Rodríguez-Enríquez, A. Marín-Hernández, and E. Saavedra. 2007. Energy metabolism in tumor cells. FEBS Journal 274 (6):1393–418. doi: 10.1111/j.1742-4658.2007.05686.x.
   PubMed Web of Science ®Google Scholar
• Morscher, R. J., S. Aminzadeh-Gohari, R. Feichtinger, J. A. Mayr, R. Lang, D. Neureiter, W. Sperl, and B. Kofler. 2015. Inhibition of neuroblastoma tumor growth by ketogenic diet and/or calorie restriction in a CD1-nu mouse model. PLoS One 10 (6):e0129802. doi: 10.1371/journal.pone.0129802.
   PubMed Web of Science ®Google Scholar
• Mukherjee, P., Z. M. Augur, M. Li, C. Hill, B. Greenwood, M. A. Domin, G. Kondakci, N. R. Narain, M. A. Kiebish, R. T. Bronson, et al. 2019. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma. Communications Biology 2 (1):200. doi: 10.1038/s42003-019-0455-x.
   PubMedGoogle Scholar
• Mulrooney, T. J., J. Marsh, I. Urits, T. N. Seyfried, and P. Mukherjee. 2011. Influence of caloric restriction on constitutive expression of NF-κb in an experimental mouse astrocytoma. PLoS One 6 (3):e18085. doi: 10.1371/journal.pone.0018085.
   PubMed Web of Science ®Google Scholar
• Nakamura, K., H. Tonouchi, A. Sasayama, and K. Ashida. 2018. A ketogenic formula prevents tumor progression and cancer cachexia by attenuating systemic inflammation in colon 26 tumor-bearing mice. Nutrients 10 (2):206. doi: 10.3390/nu10020206.
   PubMed Web of Science ®Google Scholar
• Neal, E. G., H. Chaffe, R. H. Schwartz, M. S. Lawson, N. Edwards, G. Fitzsimmons, A. Whitney, and J. H. Cross. 2008. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. The Lancet Neurology 7 (6):500–6. doi: 10.1016/S1474-4422(08)70092-9.
   PubMed Web of Science ®Google Scholar
• Nebeling, L. C., F. Miraldi, S. B. Shurin, and E. Lerner. 1995. Effects of a Ketogenic Diet on Tumor Metabolism and Nutritional Status in Pediatrie Oncology Patients: Two Case Reports. Journal of the American College of Nutrition 14 (2):202–8. doi: 10.1080/07315724.1995.10718495.
   PubMed Web of Science ®Google Scholar
• Newman, J. C., and E. Verdin. 2014. Ketone bodies as signaling metabolites. Trends in Endocrinology and Metabolism 25 (1):42–52. doi: 10.1016/j.tem.2013.09.002.
   PubMed Web of Science ®Google Scholar
• Ota, M., J. Matsuo, I. Ishida, H. Takano, Y. Yokoi, H. Hori, S. Yoshida, K. Ashida, K. Nakamura, T. Takahashi, et al. 2019. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease. Neuroscience Letters 690:232–6. doi: 10.1016/j.neulet.2018.10.048.
   PubMed Web of Science ®Google Scholar
• Page, K. A., A. Williamson, N. Yu, E. C. McNay, J. Dzuira, R. J. McCrimmon, and R. S. Sherwin. 2009. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes 58 (5):1237–44. doi: 10.2337/db08-1557.
   PubMed Web of Science ®Google Scholar
• Paoli, A. 2014. Ketogenic diet for obesity: Friend or foe? International Journal of Environmental Research and Public Health 11 (2):2092–107. doi: 10.3390/ijerph110202092.
   PubMed Web of Science ®Google Scholar
• Paoli, A., A. Bianco, E. Damiani, and G. Bosco. 2014. Ketogenic diet in neuromuscular and neurodegenerative diseases. BioMed Research International 2014:474296. doi: 10.1155/2014/474296.
   PubMed Web of Science ®Google Scholar
• Papandreou, I., R. A. Cairns, L. Fontana, A. L. Lim, and N. C. Denko. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metabolism 3 (3):187–97. doi: 10.1016/j.cmet.2006.01.012.
   PubMed Web of Science ®Google Scholar
• Park, Y., L. L. Peterson, and G. A. Colditz. 2018. The plausibility of obesity paradox in cancer. Cancer Research 78 (8):1898–903. doi: 10.1158/0008-5472.CAN-17-3043.
   PubMed Web of Science ®Google Scholar
• Pelletier, A., and L. Coderre. 2007. Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes. American Journal of Physiology - Endocrinology and Metabolism 292 (5):E1325–32. doi: 10.1152/ajpendo.00186.2006.
   PubMed Web of Science ®Google Scholar
• Phinney, S. D., B. R. Bistrian, R. R. Wolfe, and G. L. Blackburn. 1983. The human metabolic response to chronic ketosis without caloric restriction: Physical and biochemical adaptation. Metabolism 32 (8):757–68. doi: 10.1016/0026-0495(83)90105-1.
   PubMed Web of Science ®Google Scholar
• Pischon, T., P. H. Lahmann, H. Boeing, C. Friedenreich, T. Norat, A. Tjønneland, J. Halkjaer, K. Overvad, F. Clavel-Chapelon, M. C. Boutron-Ruault, et al. 2006. Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Journal of the National Cancer Institute 98 (13):920–31. doi: 10.1093/jnci/djj246.
   PubMedGoogle Scholar
• Poff, A., A. P. Koutnik, K. M. Egan, S. Sahebjam, D. D’Agostino, and N. B. Kumar. 2019. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Seminars in Cancer Biology 56:135–48. doi: 10.1016/j.semcancer.2017.12.011.
   PubMed Web of Science ®Google Scholar
• Poff, A. M., C. Ari, P. Arnold, T. N. Seyfried, and D. P. D’Agostino. 2014. Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer. International Journal of Cancer 135 (7):1711–20. doi: 10.1002/ijc.28809.
   PubMed Web of Science ®Google Scholar
• Poff, A. M., C. Ari, T. N. Seyfried, and D. P. D’Agostino. 2013. The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One 8 (6):e65522. doi: 10.1371/journal.pone.0065522.
   PubMed Web of Science ®Google Scholar
• Portakal, O., ÖZay Özkaya, M. Erden İNal, B. Bozan, M. Koşan, and I. Sayek. 2000. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clinical Biochemistry 33 (4):279–84. doi: 10.1016/S0009-9120(00)00067-9.
   PubMed Web of Science ®Google Scholar
• Prado, C. M., M. B. Sawyer, S. Ghosh, J. R. Lieffers, N. Esfandiari, S. Antoun, and V. E. Baracos. 2013. Central tenet of cancer cachexia therapy: Do patients with advanced cancer have exploitable anabolic potential? American Journal of Clinical Nutrition 98 (4):1012–9. doi: 10.3945/ajcn.113.060228.
   PubMed Web of Science ®Google Scholar
• Raglan, O., I. Kalliala, G. Markozannes, S. Cividini, M. J. Gunter, J. Nautiyal, H. Gabra, E. Paraskevaidis, P. Martin-Hirsch, K. K. Tsilidis, et al. 2019. Risk factors for endometrial cancer: An umbrella review of the literature. International Journal of Cancer 145 (7):1719–30. doi: 10.1002/ijc.31961.
   PubMed Web of Science ®Google Scholar
• Rauckhorst, A. J., and E. B. Taylor. 2016. Mitochondrial pyruvate carrier function and cancer metabolism. Current Opinion in Genetics and Development 38:102–9. doi: 10.1016/j.gde.2016.05.003.
   PubMed Web of Science ®Google Scholar
• Ressel, G. W. 2002. American Cancer Society releases guidelines on nutrition and physical activity for cancer prevention. American Family Physician 66 (8):1555, 1559–60, 1562.
   PubMed Web of Science ®Google Scholar
• Rieger, J., O. Bähr, G. D. Maurer, E. Hattingen, K. Franz, D. Brucker, S. Walenta, U. Kämmerer, J. F. Coy, M. Weller, et al. 2014. ERGO: A pilot study of ketogenic diet in recurrent glioblastoma. International Journal of Oncology 44 (6):1843–52. doi: 10.3892/ijo.2014.2382.
   PubMed Web of Science ®Google Scholar
• Ruan, K., G. Song, and G. Ouyang. 2009. Role of hypoxia in the hallmarks of human cancer. Journal of Cellular Biochemistry 107 (6):1053–62. doi: 10.1002/jcb.22214.
   PubMed Web of Science ®Google Scholar
• Sadeghi, M., M. Keshavarz-Fathi, V. Baracos, J. Arends, M. Mahmoudi, and N. Rezaei. 2018. Cancer cachexia: Diagnosis, assessment, and treatment. Critical Reviews in Oncology/Hematology 127:91–104. doi: 10.1016/j.critrevonc.2018.05.006.
   PubMed Web of Science ®Google Scholar
• Saltiel, A. R., and J. M. Olefsky. 2017. Inflammatory mechanisms linking obesity and metabolic disease. Journal of Clinical Investigation 127 (1):1–4. doi: 10.1172/JCI92035.
   PubMed Web of Science ®Google Scholar
• Sawai, M., M. Yashiro, Y. Nishiguchi, M. Ohira, and K. Hirakawa. 2004. Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA: 3-Oxoacid CoA-transferase (SCOT) deficiency. Anticancer Research 24 (4):2213–7.
   PubMed Web of Science ®Google Scholar
• Scalise, M., L. Pochini, M. Galluccio, L. Console, and C. Indiveri. 2017. Glutamine transport and mitochondrial metabolism in cancer cell growth. Frontiers in Oncology 7:306. doi: 10.3389/fonc.2017.00306.
   PubMed Web of Science ®Google Scholar
• Schmidt, M., N. Pfetzer, M. Schwab, I. Strauss, and U. Kämmerer. 2011. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutrition and Metabolism 8 (1):54. doi: 10.1186/1743-7075-8-54.
   Google Scholar
• Schumacker, P. T. 2006. Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell 10 (3):175–6. doi: 10.1016/j.ccr.2006.08.015.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. 2010. HIF-1: Upstream and downstream of cancer metabolism. Current Opinion in Genetics and Development 20 (1):51–6. doi: 10.1016/j.gde.2009.10.009.
   PubMed Web of Science ®Google Scholar
• Seyfried, T. N., T. M. Sanderson, M. M. El-Abbadi, R. McGowan, and P. Mukherjee. 2003. Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. British Journal of Cancer 89 (7):1375–82. doi: 10.1038/sj.bjc.6601269.
   PubMed Web of Science ®Google Scholar
• Seyfried, T. N., L. Shelton, G. Arismendi-Morillo, M. Kalamian, A. Elsakka, J. Maroon, and P. Mukherjee. 2019. Provocative question: Should ketogenic metabolic therapy become the standard of care for glioblastoma? Neurochemical Research 44 (10):2392–404. doi: 10.1007/s11064-019-02795-4.
   PubMed Web of Science ®Google Scholar
• Seyfried, T. N., G. Yu, J. C. Maroon, and D. P. D’Agostino. 2017. Press-pulse: A novel therapeutic strategy for the metabolic management of cancer. Nutrition and Metabolism 14:19. doi: 10.1186/s12986-017-0178-2.
   Google Scholar
• Shang, S., L. Wang, Y. Zhang, H. Lu, and X. Lu. 2018. The Beta-Hydroxybutyrate Suppresses the Migration of Glioma Cells by Inhibition of NLRP3 Inflammasome. Cellular and Molecular Neurobiology 38 (8):1479–89. doi: 10.1007/s10571-018-0617-2.
   PubMed Web of Science ®Google Scholar
• Shaw, E., M. Farris, J. McNeil, C. Friedenreich. 2016. Obesity and endometrial cancer. In Obesity and cancer, eds. T. Pischon and K. Nimptsch. Recent results in cancer research. 208:107–36. doi: 10.1007/978-3-319-42542-9_7.
   Google Scholar
• Shimazu, T., M. D. Hirschey, J. Newman, W. He, K. Shirakawa, N. Le Moan, C. A. Grueter, H. Lim, L. R. Saunders, R. D. Stevens, et al. 2013. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339 (6116):211–4. doi: 10.1126/science.1227166.
   PubMed Web of Science ®Google Scholar
• Shukla, S. K., T. Gebregiworgis, V. Purohit, N. V. Chaika, V. Gunda, P. Radhakrishnan, K. Mehla, I. I. Pipinos, R. Powers, F. Yu, et al. 2014. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer & Metabolism 2:18. doi: 10.1186/2049-3002-2-18.
   PubMedGoogle Scholar
• Siegel, R. L., K. D. Miller, and A. Jemal. 2019. Cancer statistics, 2019. CA: A Cancer Journal for Clinicians 69 (1):7–34. doi: 10.3322/caac.21551.
   PubMed Web of Science ®Google Scholar
• Simone, B. A., A. Palagani, K. Strickland, K. Ko, L. Jin, M. K. Lim, T. D. Dan, M. Sarich, D. A. Monti, M. Cristofanilli, et al. 2018. Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model. Cell Cycle 17 (13):1536–44. doi: 10.1080/15384101.2018.1471314.
   PubMed Web of Science ®Google Scholar
• Skinner, R., A. Trujillo, X. Ma, and E. A. Beierle. 2009. Ketone bodies inhibit the viability of human neuroblastoma cells. Journal of Pediatric Surgery 44 (1):212–6. doi: 10.1016/j.jpedsurg.2008.10.042.
   PubMed Web of Science ®Google Scholar
• Sowers, J. L., K. M. Johnson, C. Conrad, J. T. Patterson, and L. C. Sowers. 2014. The role of inflammation in brain cancer. In Inflammation and cancer. Advances in experimental medicine and biology, eds. B. Aggarwal, B. Sung, and S. Gupta, 75–105. Basel: Springer. doi: 10.1007/978-3-0348-0837-8_4.
   Google Scholar
• Stafford, P., M. G. Abdelwahab, D. Y. Kim, M. C. Preul, J. M. Rho, and A. C. Scheck. 2010. The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutrition and Metabolism 7:74. doi: 10.1186/1743-7075-7-74.
   Google Scholar
• Stattin, P., O. Björ, P. Ferrari, A. Lukanova, P. Lenner, B. Lindahl, G. Hallmans, and R. Kaaks. 2007. Prospective study of hyperglycemia and cancer risk. Diabetes Care 30 (3):561–7. doi: 10.2337/dc06-0922.
   PubMed Web of Science ®Google Scholar
• Sung, B., S. Prasad, V. R. Yadav, A. Lavasanifar, and B. B. Aggarwal. 2011. Cancer and diet: How are they related? Free Radical Research 45 (8):864–79. doi: 10.3109/10715762.2011.582869.
   PubMed Web of Science ®Google Scholar
• Tan-Shalaby, J. 2017. Ketogenic diets and cancer: Emerging evidence. Federal Practitioner 34 (Suppl 1):37S–2S.
   PubMedGoogle Scholar
• Terzikhan, N., E. L. Doets, and M. Vonk Noordegraaf‐Schouten. 2015. Extensive literature search and review as preparatory work for the evaluation of the essential composition of total diet replacement products for weight control. EFSA Supporting Publications 12 (1):590. doi: 10.2903/sp.efsa.2015.EN-590.
   Google Scholar
• Tisdale, M. J., R. A. Brennan, and K. C. Fearon. 1987. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. British Journal of Cancer 56 (1):39–43. doi: 10.1038/bjc.1987.149.
   PubMed Web of Science ®Google Scholar
• Trestini, I., L. Carbognin, C. Bonaiuto, G. Tortora, and E. Bria. 2018. The obesity paradox in cancer: Clinical insights and perspectives. Eating and Weight Disorders 23 (2):185–93. doi: 10.1007/s40519-018-0489-y.
   PubMed Web of Science ®Google Scholar
• Unterlass, J. E., and N. J. Curtin. 2019. Warburg and Krebs and related effects in cancer. Expert Reviews in Molecular Medicine 21:e4. doi: 10.1017/erm.2019.4.
   PubMed Web of Science ®Google Scholar
• van der Louw, E. J. T. M., J. F. Olieman, P. M. L. A. van den Bemt, J. E. C. Bromberg, E. Oomen-de Hoop, R. F. Neuteboom, C. E. Catsman-Berrevoets, and A. J. P. E. Vincent. 2019. Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: A feasibility and safety study. Therapeutic Advances in Medical Oncology 11:1758835919853958. doi: 10.1177/1758835919853958.
   Web of Science ®Google Scholar
• van Dijk, D. P. J., M. C. G. van de Poll, A. G. W. Moses, T. Preston, S. W. M. Olde Damink, S. S. Rensen, N. E. P. Deutz, P. B. Soeters, J. A. Ross, K. C. H. Fearon, et al. 2015. Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients. Journal of Cachexia, Sarcopenia and Muscle 6 (3):212–21. doi: 10.1002/jcsm.12029.
   PubMed Web of Science ®Google Scholar
• Veech, R. L. 2004. The therapeutic implications of ketone bodies: The effects of ketone bodies in pathological conditions: Ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukotrienes and Essential Fatty Acids 70 (3):309–19. doi: 10.1016/j.plefa.2003.09.007.
   PubMed Web of Science ®Google Scholar
• Veech, R. L., B. Chance, Y. Kashiwaya, H. A. Lardy, and G. F. Cahill. 2001. Ketone bodies, potential therapeutic uses. IUBMB Life 51 (4):241–7. doi: 10.1080/152165401753311780.
   PubMed Web of Science ®Google Scholar
• Volek, J. S., S. D. Phinney, C. E. Forsythe, E. E. Quann, R. J. Wood, M. J. Puglisi, W. J. Kraemer, D. M. Bibus, M. L. Fernandez, and R. D. Feinman. 2009. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 44 (4):297–309. doi: 10.1007/s11745-008-3274-2.
   PubMed Web of Science ®Google Scholar
• Volek, J. S., and M. J. Sharman. 2004. Cardiovascular and hormonal aspects of very-low-carbohydrate ketogenic diets. Obesity Research 12 (S11):115S–23S. doi: 10.1038/oby.2004.276.
   PubMedGoogle Scholar
• Volek, J. S., M. J. Sharman, A. L. Gómez, C. DiPasquale, M. Roti, A. Pumerantz, and W. J. Kraemer. 2004. Comparison of a very low-carbohydrate and low-fat diet on fasting lipids, LDL subclasses, insulin resistance, and postprandial lipemic responses in overweight women. Journal of the American College of Nutrition 23 (2):177–84. doi: 10.1080/07315724.2004.10719359.
   PubMed Web of Science ®Google Scholar
• Vucenik, I., and J. P. Stains. 2012. Obesity and cancer risk: Evidence, mechanisms, and recommendations. Annals of the New York Academy of Sciences 1271 (1):37–43. doi: 10.1111/j.1749-6632.2012.06750.x.
   PubMedGoogle Scholar
• Wang, J., and J. Yi. 2008. Cancer cell killing via ROS: To increase or decrease, that is a question. Cancer Biology and Therapy 7 (12):1875–84. doi: 10.4161/cbt.7.12.7067.
   PubMed Web of Science ®Google Scholar
• Warburg, O. 1956. On the origin of cancer cells. Science (New York, N.Y.) 123 (3191):309–14. doi: 10.1126/science.123.3191.309.
   PubMed Web of Science ®Google Scholar
• Watanabe, M., R. Tozzi, R. Risi, D. Tuccinardi, S. Mariani, S. Basciani, G. Spera, C. Lubrano, and L. Gnessi. 2020. Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature. Obesity Reviews 21 (8):e13024. doi: 10.1111/obr.13024.
   PubMed Web of Science ®Google Scholar
• Weber, D. D., S. Aminazdeh-Gohari, and B. Kofler. 2018. Ketogenic diet in cancer therapy. Aging 10 (2):164–5. doi: 10.18632/aging.101382.
   PubMedGoogle Scholar
• Weber, D. D., S. Aminzadeh-Gohari, J. Tulipan, L. Catalano, R. G. Feichtinger, and B. Kofler. 2020. Ketogenic diet in the treatment of cancer – Where do we stand? Molecular Metabolism 33:102–21. doi: 10.1016/j.molmet.2019.06.026.
   PubMed Web of Science ®Google Scholar
• Weinhouse, S. 1976. The Warburg hypothesis fifty years later. Zeitschrift für Krebsforschung und Klinische Onkologie 87 (2):115–26. doi: 10.1007/BF00284370.
   Google Scholar
• Weinhouse, S., O. Warburg, D. Burk, and A. L. Schade. 1956. On respiratory impairment in cancer cells. Science (New York, N.Y.) 124 (3215):267–9. doi: 10.1126/science.124.3215.267.
   PubMedGoogle Scholar
• Wheless, J. W. 2008. History of the ketogenic diet. Epilepsia 49:3–5. doi: 10.1111/j.1528-1167.2008.01821.x.
   PubMed Web of Science ®Google Scholar
• Wiseman, H., and B. Halliwell. 1996. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochemical Journal 313 (1):17–29. doi: 10.1042/bj3130017.
   PubMed Web of Science ®Google Scholar
• Woolf, E. C., K. L. Curley, Q. Liu, G. H. Turner, J. A. Charlton, M. C. Preul, and A. C. Scheck. 2015. The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma model. PLoS One 10 (6):e0130357. doi: 10.1371/journal.pone.0130357.
   PubMed Web of Science ®Google Scholar
• Woolf, E. C., N. Syed, and A. C. Scheck. 2016. Tumor metabolism, the ketogenic diet and β-hydroxybutyrate: Novel approaches to adjuvant brain tumor therapy. Frontiers in Molecular Neuroscience 9:122. doi: 10.3389/fnmol.2016.00122.
   PubMed Web of Science ®Google Scholar
• Wu, K., X. Yu, Z. Huang, D. Zhu, X. Yi, Y. L. Wu, Q. Hao, K. T. Kemp, Y. Elshimali, R. Iyer, et al. 2019. Targeting of PP2Cδ by a small molecule C23 inhibits high glucose-induced breast cancer progression in vivo. Antioxidants and Redox Signaling 30 (17):1983–98. doi: 10.1089/ars.2017.7486.
   PubMed Web of Science ®Google Scholar
• Xia, S., R. Lin, L. Jin, L. Zhao, H. B. Kang, Y. Pan, S. Liu, G. Qian, Z. Qian, E. Konstantakou, et al. 2017. Prevention of dietary-fat-fueled ketogenesis attenuates BRAF V600E tumor growth. Cell Metabolism 25 (2):358–73. doi: 10.1016/j.cmet.2016.12.010.
   PubMed Web of Science ®Google Scholar
• Xu, R. H., H. Pelicano, Y. Zhou, J. S. Carew, L. Feng, K. N. Bhalla, M. J. Keating, and P. Huang. 2005. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Research 65 (2):613–21.
   PubMed Web of Science ®Google Scholar
• Yancy, W. S., M. K. Olsen, J. R. Guyton, R. P. Bakst, and E. C. Westman. 2004. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: A randomized, controlled trial. Annals of Internal Medicine 140 (10):769. doi: 10.7326/0003-4819-140-10-200405180-00006.
   PubMed Web of Science ®Google Scholar
• Youm, Y.-H., K. Y. Nguyen, R. W. Grant, E. L. Goldberg, M. Bodogai, D. Kim, D. D’Agostino, N. Planavsky, C. Lupfer, T. D. Kanneganti, et al. 2015. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature Medicine 21 (3):263–9. doi: 10.1038/nm.3804.
   PubMed Web of Science ®Google Scholar
• Zahra, A., M. A. Fath, E. Opat, K. A. Mapuskar, S. K. Bhatia, D. C. Ma, S. N. R. Iii, T. P. Snyders, C. A. Chenard, J. M. Eichenberger-Gilmore, et al. 2017. Consuming a ketogenic diet while receiving radiation and chemotherapy for locally advanced lung cancer and pancreatic cancer: The University of Iowa experience of two phase 1 clinical trials. Radiation Research 187 (6):743–54. doi: 10.1667/RR14668.1.
   PubMed Web of Science ®Google Scholar
• Zhang, H., P. Gao, R. Fukuda, G. Kumar, B. Krishnamachary, K. I. Zeller, C. V. V. Dang, and G. L. Semenza. 2007. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11 (5):407–20. doi: 10.1016/j.ccr.2007.04.001.
   PubMed Web of Science ®Google Scholar
• Zhou, W., P. Mukherjee, M. A. Kiebish, W. T. Markis, J. G. Mantis, and T. N. Seyfried. 2007. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutrition and Metabolism 4:5. doi: 10.1186/1743-7075-4-5.
   Google Scholar
• Zhou, X., J. Yu, L. Li, V. L. Gloy, A. Nordmann, M. Tiboni, Y. Li, and X. Sun. 2016. Effects of bariatric surgery on mortality, cardiovascular events, and cancer outcomes in obese patients: Systematic review and meta-analysis. Obesity Surgery 26 (11):2590–601. doi: 10.1007/s11695-016-2144-x.
   PubMed Web of Science ®Google Scholar